Logos Global Management’s Ambrx Biopharma Inc AMAM Stock Holding History

Logos Global Management’s Portfolio AMAM Stock Details AMAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-2,100,000	Closed	-$29.9M	–	78
2023 Q4	$29.9M	Buy	2,100,000 +1,985,000	+1,726%	+$22.6M	2.79%	12
2023 Q3	$1.32M	Buy	+115,000	New	+$1.57M	0.18%	49

Logos Global Management's AMAM Position: Q1 2024 in Review

Logos Global Management sold out of Ambrx Biopharma Inc (AMAM) in Q1 2024, closing a stake of 2,100,000 shares — an estimated $29.9M sold.

Logos Global Management first reported a position in AMAM in Q3 2023 and held it in 2 quarters. The position peaked at $29.9M in Q4 2023. 0 funds tracked by Wall St. Rank hold AMAM as of Q1 2024.

Logos Global Management reported no remaining Ambrx Biopharma Inc position as of Q1 2024 after selling out during the quarter.
Logos Global Management sold 2,100,000 Ambrx Biopharma Inc shares in Q1 2024, an estimated $29.9M.
Logos Global Management first reported a position in Ambrx Biopharma Inc in Q3 2023 and held it in 2 quarters.
Logos Global Management's Ambrx Biopharma Inc position peaked at $29.9M in Q4 2023.
0 funds tracked by Wall St. Rank held Ambrx Biopharma Inc as of Q1 2024.

Based on Logos Global Management's 13F filing for Q1 2024, filed 15 May 2024.